Evidence map›Paper›PMID 40948118›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2025

Levodopa Disrupts Activity Patterns and Encoding of Movement in Striatal Cholinergic Interneurons of Behaving Mice.

Yara Atamna, Lior Tiroshi, Nadine Wattad, Naomi Gilin, Shelly Gilad, Noa Berkowitz, Joshua A Goldberg

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Is levodopa induced freezing of gait a paradox or an expected phenomenon?: a clinico-pathophysiological hypothesis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yara AtamnaDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-2389-7960
Lior TiroshiDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0001-5634-4484
Nadine WattadDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0009-0002-2704-0873
Naomi GilinDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0003-0638-532X
Shelly GiladDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0009-0002-4506-7754
Noa BerkowitzDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-1313-4708
Joshua A GoldbergDepartment of Medical Neurobiology, Institute of Medical Research Israel - Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0000-0002-5740-4087

Funding

European Research Council 646886Israel Science Foundation 154/14Israel Science Foundation 155/14Israel Science Foundation 1959/22United States-Israel Binational Science Foundation 2021212
6 · The paper itself

Abstract

objectivesLevodopa treatment, the gold standard therapy for Parkinson's disease, can lead to levodopa-induced dyskinesias (LIDs). Recent studies in acute brain slices have implicated the neural dynamics of striatal cholinergic interneurons (CINs) in the pathophysiology of LID, reporting that their discharge becomes more bursty in dyskinetic mice. However, little is known about how parkinsonism and levodopa affect CINs in vivo.

methodsWe used microendoscopic imaging in the dorsal striatum of the genetically encoded Ca

resultsWe found that 6-OHDA drove a levodopa-insensitive increase in the baseline rate of activity of CINs and a reduction in their responsiveness to self-initiated movement. Furthermore, levodopa treatment (even before the appearance of LIDs) drove an increase in the amplitude of the individual Ca

conclusions6-OHDA treatment disrupts the robust encoding of movement by CINs. Levodopa disrupts the activity of CINs, possibly making them more bursty in vivo, even before the manifestation of LIDs. Thus, molecularly-identified CINs are implicated in the pathophysiology of parkinsonism. Not only does levodopa fail to restore their normal dynamics, but it actually exacerbates their abnormal burstiness. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Antiparkinson AgentsCholinergic NeuronsCorpus StriatumDyskinesia, Drug-InducedInterneuronsLevodopaAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, TransgenicMovementOxidopamineParkinsonian DisordersAntiparkinson AgentsLevodopaOxidopamineexperimental parkinsonismin vivo microendoscopylevodopa‐induced dyskinesiaspathophysiologystriatal acetylcholine

Identifiers

PMID40948118
PMCPMC13001710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.